Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
Cepsa Tower, the company's new corporate headquarters that houses almost 2,000 people, is Spain's second tallest building and represents the materialization of Cepsa's growth and internationalization strategy of in recent years, following the entry of International Petroleum Investment Company (IPIC), as sole shareholder.
The headquarters, designed by the architect Norman Foster, reflects the transformation of Cepsa's business model to focus on an increasingly international market. Its height, at 248 metres, provides a unique view of Madrid from its upper floors, taking in some of the city's most emblematic locations such as the Paseo de la Castellana, the Parque del Retiro and the Santiago Bernabéu stadium.
Cepsa today operates an integrated business model spanning the entire hydrocarbon value chain. This integration allows the company to act with greater flexibility and the ability to respond quickly as a business.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7703451-cepsa-new-headquarters-new-company/
The Heart Rhythm Society (HRS), through its efforts during Atrial Fibrillation Awareness Month in September and throughout the year, is working to raise awareness of the increased prevalence of the disease and the associated risk of stroke in patients living with atrial fibrillation (AFib). Today, HRS releases a new public service announcement (PSA) as part of its ongoing work to educate Americans about AFib, the most common heart arrhythmia, and how it increases one’s risk of stroke fivefold. The PSA can be viewed by clicking here.
AFib affects more than three million Americans and it is estimated that 12 to 16 million Americans will have AFib by 2050. AFib occurs when the upper chambers of the heart (the atria) fibrillate, or “quiver,” which causes a rapid, irregular heart rhythm. The normal heart rate for an adult is between 60 and 100 beats every minute. When the heart is experiencing AFib, the atria can beat over 300 times every minute.
To view the multimedia release go to:
http://www.multivu.com/players/English/7312151-heart-rhythm-society-afib-stroke-psa/
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
SEDCO Holding Group showcases its previous accomplishments and perceives sustained growth through further expansion in its investment ventures over the next 10 years. This prominent Group outlook was unraveled at its annual “Multaqa SEDCO 2015” held at Leylaty Ballroom in Jeddah, attended by the Group’s upper management notably Sheikh Saleh Salem Bin Mahfouz, Chairman of the Board and Mr. Anees Moumina, CEO of the Group. The event also gathered the heads of its operating companies, CEOs and senior executives, management boards, their partners along with the administrative cadre.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7525651-multaqa-sedco-2015/
Trigenic Flex is the latest design innovation from Clarks Originals: the culmination of over 190 years’ expertise in the craft of shoemaking. With a tradition of introducing innovative footwear to the marketplace, the brand’s unconventional, and sometimes radical, approach has resulted in the proliferation of globally recognised icons such as The Desert Boot and Wallabee®.
Continuing this ‘free-thinking’ design philosophy, Clarks fuses a shoemaker’s craft and traditions with advanced technology and innovation to deliver the Trigenic Flex; an icon in the making. The Trigenic Flex is a beautifully crafted and truly original everyday shoe with a design that is deconstructed to create a minimal and fresh look.
The Trigenic Flex takes inspiration from an original 1883 Clarks Hygiene design; stylish shoes that were shaped to the natural contours of the foot, a great contrast to the seriously uncomfortable and deforming fashions of the time. Prad Indrakumar, Senior Designer, Clarks Originals, states:
“We started by looking at the Clarks ‘Hygienic’ collection of 1883. This was a collection that allowed space for the toes of your foot to move as you walked - revolutionary for its time. We looked at how we could bring this into a modern context.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7732251-clarks-create-trigenic-flex-new-classic/
Discover comprehensive posture corrector and shoulder braces guides and reviews at http://posturecorrectorbrace.com. In addition to helpful user experience based posture brace reviews this posture improvement portal offers lower back pain, shoulder pain and upper back pain alleviation tips.
